What is axial3D?
Axial3D operates at the intersection of medical diagnostics and advanced software engineering. The company specializes in developing proprietary AI-driven platforms that automate the conversion of standard 2D medical imaging into high-fidelity, data-rich 3D visualizations. This technology is designed to streamline the workflow for surgeons and radiologists, providing a more intuitive understanding of patient anatomy. By reducing the time and technical expertise required for complex 3D modeling, Axial3D is effectively democratizing access to advanced surgical planning tools, positioning itself as a key player in the global health-tech ecosystem.
How much funding has axial3D raised?
axial3D has raised a total of $36.9M across 4 funding rounds:
Angel/Seed
$660K
Unspecified
$3M
Unspecified
$15M
Other Financing Round
$18.2M
Angel/Seed (2017): $660K with participation from Techstart NI
Unspecified (2019): $3M led by Techstart Ventures, Clarendon Fund Managers, Innovation Ulster, and Imprimatur Capital Fund Management
Unspecified (2022): $15M supported by Stratasys
Other Financing Round (2024): $18.2M featuring Techstart Ventures, Clarendon Homes, and Innovation Ulster
Key Investors in axial3D
Techstart Ventures
A seed-stage venture capital firm focused on supporting ambitious entrepreneurial teams in Scotland and Northern Ireland through experienced guidance and equity financing.
Stratasys
A global leader in polymer 3D printing and additive manufacturing solutions, providing the infrastructure necessary to bring complex medical designs to physical reality.
Innovation Ulster
A Belfast-based entity specializing in custom software and IT services, providing strategic support to regional technology ventures.
What's next for axial3D?
With the successful closure of this major enterprise-level funding round, Axial3D is well-positioned to accelerate its international market penetration and deepen its R&D capabilities. The strategic alignment with industry leaders in additive manufacturing and specialized venture capital suggests a roadmap focused on scaling its software-as-a-service (SaaS) offerings and integrating more deeply into hospital infrastructure. As the demand for personalized medicine and precision surgery continues to rise, the company is expected to focus on expanding its clinical validation studies and enhancing its AI algorithms to support a broader range of medical specialties, ultimately aiming to set a new global standard for diagnostic and treatment planning efficiency.
See full axial3D company page
